26468 | test1111 | testuser | 03/06/2014 7:15:44 PM |
26467 | test1111 | testuser | 03/06/2014 7:15:43 PM |
26466 | test1111 | testuser | 03/06/2014 7:15:42 PM |
26465 | test1111 | testuser | 03/06/2014 7:15:41 PM |
26464 | test | testuser | 02/22/2014 8:34:09 PM |
26463 | testing | testuser | 02/21/2014 5:02:09 PM |
26462 | test | testuser | 02/21/2014 3:46:34 PM |
26461 | test | testuser | 02/21/2014 3:45:36 PM |
26460 | test | testuser | 02/21/2014 3:40:40 PM |
26459 | testing | testuser | 02/21/2014 1:30:22 PM |
26458 | New post from saurabh | saurabh | 02/21/2014 1:43:02 AM |
26457 | reply test test public | saurabh | 02/21/2014 1:42:11 AM |
26456 | test reply from saurabh | saurabh | 02/21/2014 1:39:37 AM |
26455 | test check | testuser | 02/20/2014 7:22:20 PM |
26453 | New post test baby test | saurabh | 02/20/2014 3:06:33 AM |
26452 | public reply baby test test | saurabh | 02/20/2014 3:03:00 AM |
26451 | New public reply | itest | 02/20/2014 3:02:32 AM |
26450 | test public rely by saurabh | saurabh | 02/20/2014 2:58:12 AM |
26449 | test public reply again | itest | 02/19/2014 8:56:11 AM |
26448 | test public reply | itest | 02/19/2014 8:55:15 AM |
26447 | test? | testuser | 02/18/2014 5:05:59 PM |
26446 | this is a test ? | testuser | 02/18/2014 5:03:53 PM |
26445 | nice = | testuser | 02/18/2014 5:03:21 PM |
26444 | View_testing_something_123456 | testuser | 02/17/2014 10:28:27 PM |
26443 | this is a test for ih. | testuser | 02/17/2014 9:38:04 PM |
26442 | vvv | testuser | 02/17/2014 9:30:55 PM |
26441 | bbb | testuser | 02/17/2014 9:29:31 PM |
26440 | g | testuser | 02/17/2014 9:29:08 PM |
26439 | A | testuser | 02/17/2014 8:35:39 PM |
26438 | dhshdjsjdhdehehrejruwueudhshshdhdhssjsjdjdjdjejsj | testuser | 02/17/2014 7:20:46 PM |
26437 | HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH101000000191919 | testuser | 02/17/2014 7:20:17 PM |
26436 | H_H | testuser | 02/17/2014 7:19:16 PM |
26435 | H | testuser | 02/17/2014 7:18:47 PM |
26434 | dsdffsddfsfd | testuser | 02/16/2014 11:43:36 AM |
26433 | why? | testuser | 02/16/2014 11:38:27 AM |
26432 | no | testuser | 02/16/2014 11:38:19 AM |
26431 | stop ok? | testuser | 02/16/2014 11:38:11 AM |
26430 | just a few more. | testuser | 02/16/2014 11:38:00 AM |
26429 | lol | testuser | 02/16/2014 11:37:47 AM |
26428 | change that | testuser | 02/16/2014 11:37:25 AM |
26427 | yes | testuser | 02/16/2014 11:37:16 AM |
26426 | sdfjlasdfja;dl | testuser | 02/16/2014 11:36:25 AM |
26425 | testing | testuser | 02/16/2014 11:36:16 AM |
26424 | testing | testuser | 02/16/2014 11:36:04 AM |
26423 | testing 32324435454351ddfdf | testuser | 02/16/2014 11:35:55 AM |
26422 | testing 32324435454351 | testuser | 02/16/2014 11:35:48 AM |
26421 | hi for p 2 | testuser | 02/16/2014 11:03:01 AM |
26420 | hi | testuser | 02/15/2014 6:46:30 PM |
26419 | hi | testuser | 02/15/2014 6:44:31 PM |
26418 | hi pal! | testuser | 02/15/2014 6:43:29 PM |
Recent Articles
- Significant Internet Disruptions Across Asia and Middle East
- Tether's CEO Denies Bitcoin Sales, Eyes Future Investments
- Exciting Updates from Faraday Future Ahead of 919 Futurist Day
- Fujitsu Launches Innovative AI Technology for Energy Efficiency
- Elon Musk's Vision: Tesla's Advanced AI Chips Transforming Tech
- Cryptocurrency Markets React To Key Economic Influences
- Epigenic Therapeutics Secures $60 Million to Enhance Therapies
- Danaher Corporation Faces Investigation for Fiduciary Duties
- WSPN's Strategic Acquisition of Aplauz NL B.V. Enhances Growth
- Shigeru Ishiba's Resignation: A New Era for Japan's Trade Policies
- Sunset World Group's Commitment to Sea Turtle Conservation Efforts
- InnoCare Pharma's Breakthrough Approval for HIBRUKA in Singapore
- Innovent Unveils Encouraging Phase 2 Study Results for Tigulixostat
- Hugel Expands Its Reach with Strategic Partnership in Brazil
- Exploring Recent Challenges for Telix Pharmaceuticals: What Investors Need to Know
- Lucid Gravity SUV Launch: A New Era for Electric Vehicles
- ACM Research Launches First High-Throughput Lithography System
- Abaxx Technologies and Qingdao International Energy Exchange Unite
- Baidu Plans New CNY-Denominated Notes Offering for Investors
- RxSight, Inc. Investors Alert: Secure Counsel Before Deadline
- Unlocking Compliance: The Future of Risk Management with AI
- DataGlobal Hub's Virtual Conference Presents AI Innovations
- Aiwyn Strengthens Its Influence with the QuickFee Acquisition
- Dianthus Therapeutics Set to Present Phase 2 MaGic Trial Insights
- Dianthus Therapeutics Boosts Hope for Myasthenia Gravis Patients
- Operation Warp Speed: A Game-Changer in Global Health
- An Inspiring Celebration Awaits: Explore LIGHT OF THE WORLD
- How Operation Warp Speed Paved the Path to Global Recovery
- Legal Insights: Dow Inc. Shareholders and Class Action Basics
- C3.ai Investors Invited to Join Class Action Against Company
- Cytovale's IntelliSep Accelerates Early Sepsis Detection Efforts
- Investors of CTO Realty Growth Should Act by Deadline
- Understanding Coffee's Value: More Than Just A Daily Habit
- Newsmax's Antitrust Complaint Against Fox News Dismissed
- Job Trends Shift: Staying Might Be the New Path to Pay Growth
- Investors of Lineage, Inc. Urged to Act Before Class Action Deadline
- European Fine on Google Sparks American Investment Debate
- ECOVACS Reveals Innovative DEEBOT X11 with PowerBoost Tech
- FDA Implements New Measures for GLP-1 Weight Loss Medications
- CATL Unveils Shenxing Pro: A Breakthrough for E-Mobility
- Stand Up Against Hate: A Movement for Religious Unity
- Paramount's Innovative Approach to Cable Networks in Streaming Era
- Join the Bumble Inc. Investigation and Protect Your Rights
- EHang Holdings Limited: Investors Investigated for Securities Violations
- Hypershell X Ultra: A Revolution in Outdoor Exoskeletons
- Exploring the Trend of Overemployment as Job Security
- Charter Communications Faces Legal Challenges: Class Action Alert
- Novo Nordisk Class Action Reminder: Investor Options Explained
- Market Signals: A Look into Silver and Economic Challenges
- Replimune Investors Alerted to Key Class Action Lawsuit Details